Certified Advisory Corp Bristol Myers Squibb CO Transaction History

Certified Advisory Corp

$882 Million
Q3 2024

A detailed history of Certified Advisory Corp transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Certified Advisory Corp holds 3,959 shares of BMY stock, worth $228,671. This represents 0.02% of its overall portfolio holdings.

Number of Shares

3,959

Holding current value

$228,671

% of portfolio

0.02%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$39.66 - $51.75 $157,013 - $204,878	3,959 New	3,959 $204,000
Q3 2023 Nov 13, 2023	SELL	$57.89 - $64.73 $1,852 - $2,071	-32 Reduced 0.87%	3,654 $212,000
Q2 2023 Aug 14, 2023	BUY	$63.71 - $70.74 $3,695 - $4,102	58 Added 1.6%	3,686 $235,000
Q1 2023 May 15, 2023	BUY	$65.71 - $74.53 $52,699 - $59,773	802 Added 28.38%	3,628 $251,000
Q4 2022 Feb 14, 2023	SELL	$68.48 - $81.09 $28,213 - $33,409	-412 Reduced 12.72%	2,826 $203,000
Q3 2022 Nov 14, 2022	BUY	$0.13 - $76.84 $54 - $32,195	419 Added 14.86%	3,238 $231,000
Q2 2022 Aug 15, 2022	BUY	$72.62 - $79.98 $2,904 - $3,199	40 Added 1.44%	2,819 $217,000
Q1 2022 May 13, 2022	BUY	$61.48 - $73.72 $170,852 - $204,867	2,779 New	2,779 $203,000
Q4 2021 Feb 14, 2022	SELL	$53.63 - $62.52 $1,984 - $2,313	-37 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$59.17 - $69.31 $2,189 - $2,564	37 New	37 $2,000
Q2 2021 Aug 16, 2021	SELL	$61.91 - $67.42 $154,960 - $168,752	-2,503 Closed	0 $0
Q1 2021 May 10, 2021	BUY	$59.34 - $66.74 $25,160 - $28,297	424 Added 20.39%	2,503 $158,000
Q2 2020 Jul 27, 2020	BUY	$54.82 - $64.09 $5,646 - $6,601	103 Added 5.21%	2,079 $122,000
Q1 2020 Apr 27, 2020	SELL	$46.4 - $67.43 $8,398 - $12,204	-181 Reduced 8.39%	1,976 $110,000
Q4 2019 Jan 29, 2020	BUY	$49.21 - $64.19 $10,038 - $13,094	204 Added 10.45%	2,157 $138,000
Q3 2019 Nov 12, 2019	BUY	$42.77 - $50.71 $8,853 - $10,496	207 Added 11.86%	1,953 $99,000
Q2 2019 Aug 07, 2019	BUY	$44.62 - $49.34 $18,026 - $19,933	404 Added 30.1%	1,746 $79,000
Q1 2019 May 07, 2019	BUY	$45.12 - $53.8 $180 - $215	4 Added 0.3%	1,342 $64,000
Q4 2018 Feb 04, 2019	SELL	$48.76 - $63.23 $7,850 - $10,180	-161 Reduced 10.74%	1,338 $69,000
Q3 2018 Nov 13, 2018	BUY	$55.19 - $62.25 $275 - $311	5 Added 0.33%	1,499 $93,000
Q2 2018 Aug 14, 2018	BUY	$50.53 - $62.98 $202 - $251	4 Added 0.27%	1,494 $82,000
Q1 2018 Apr 30, 2018	BUY	$59.92 - $68.98 $34,034 - $39,180	568 Added 61.61%	1,490 $93,000
Q4 2017 Feb 22, 2018	BUY	$59.94 - $65.35 $55,264 - $60,252	922	922 $56,000

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Certified Advisory Corp, based on Form 13F filings with the SEC.

News

Stay updated on Certified Advisory Corp with notifications on news.

Account

Certified Advisory Corp Bristol Myers Squibb CO Transaction History